- United States
- /
- Auto Components
- /
- NasdaqCM:XPEL
Spotlight On Viemed Healthcare And 2 Other Top Growth Stocks With Insider Confidence
As the S&P 500 and Nasdaq Composite reach new all-time highs following a favorable July CPI report, investor optimism is buoyed by expectations of potential Federal Reserve rate cuts. In this environment, growth companies with high insider ownership can be particularly appealing, as they often signal strong internal confidence and alignment with shareholder interests.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Upstart Holdings (UPST) | 12.5% | 93.1% |
| Prairie Operating (PROP) | 34.4% | 80.8% |
| Niu Technologies (NIU) | 37.2% | 88.1% |
| Hippo Holdings (HIPO) | 12.8% | 52.5% |
| FTC Solar (FTCI) | 23.2% | 63.1% |
| Duolingo (DUOL) | 14.1% | 36.8% |
| Credo Technology Group Holding (CRDO) | 11.5% | 36.4% |
| Cloudflare (NET) | 10.6% | 45.8% |
| Atour Lifestyle Holdings (ATAT) | 22% | 23.5% |
| Astera Labs (ALAB) | 12.5% | 37% |
Here we highlight a subset of our preferred stocks from the screener.
Viemed Healthcare (VMD)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Viemed Healthcare, Inc. operates in the United States offering home medical equipment and post-acute respiratory healthcare services, with a market cap of $275.38 million.
Operations: The company's revenue is primarily derived from its healthcare facilities and services segment, totaling $240.88 million.
Insider Ownership: 13%
Earnings Growth Forecast: 26.3% p.a.
Viemed Healthcare's earnings are expected to grow significantly, outpacing the US market, with a forecasted annual growth rate of 26.3%. Recent corporate guidance raised revenue expectations for 2025 to between US$271 million and US$277 million, reflecting optimistic future prospects. Despite being dropped from the Russell 2000 Dynamic Index, the company announced a share repurchase program to buy back up to 1.98 million shares by June 2026. Insider trading shows more buying than selling recently but not in substantial volumes.
- Navigate through the intricacies of Viemed Healthcare with our comprehensive analyst estimates report here.
- Our comprehensive valuation report raises the possibility that Viemed Healthcare is priced lower than what may be justified by its financials.
XPEL (XPEL)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: XPEL, Inc. is involved in the manufacturing, installation, sale, and distribution of protective films and coatings with a market cap of $929.25 million.
Operations: The company generates revenue of $448.90 million from its Auto Parts & Accessories segment.
Insider Ownership: 14.1%
Earnings Growth Forecast: 25% p.a.
XPEL's recent earnings report highlights a solid performance, with revenue reaching US$124.71 million in Q2 2025, up from US$109.92 million the previous year. Earnings per share increased to US$0.59 from US$0.54, indicating steady growth. While insider selling has been significant recently, analysts predict a 37.5% price increase and expect earnings to grow at 25% annually—outpacing the broader market's growth rate of 14.8%. Revenue is forecasted to grow faster than the overall market at 12.4% per year.
- Take a closer look at XPEL's potential here in our earnings growth report.
- Our valuation report unveils the possibility XPEL's shares may be trading at a discount.
Antalpha Platform Holding (ANTA)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Antalpha Platform Holding Company offers financing, technology, and risk management solutions to the crypto asset industry with a market cap of $289.34 million.
Operations: The company generates revenue primarily from its data processing segment, which amounts to $51.40 million.
Insider Ownership: 17.9%
Earnings Growth Forecast: 40.6% p.a.
Antalpha Platform Holding is poised for significant growth, with revenue expected to increase by 27.8% annually, surpassing the US market's average. Earnings are forecast to grow at a robust 40.6% per year. Despite limited financial data and recent volatility in share price, Antalpha's strategic initiatives—such as expanding its treasury plan and product offerings—aim to enhance stability and resilience in digital asset financing. Recent executive changes and shareholder-approved amendments further align leadership interests with company performance goals.
- Get an in-depth perspective on Antalpha Platform Holding's performance by reading our analyst estimates report here.
- In light of our recent valuation report, it seems possible that Antalpha Platform Holding is trading beyond its estimated value.
Next Steps
- Explore the 186 names from our Fast Growing US Companies With High Insider Ownership screener here.
- Looking For Alternative Opportunities? Outshine the giants: these 20 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqCM:XPEL
XPEL
Manufactures, installs, sells, and distributes protective films, coatings and related services.
Flawless balance sheet with proven track record.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives
Micron’s AI Crown Sits on a Cycle That Hasn’t Changed
63% Profit Growth, 6.8× Forward P/E: Inside CWG Plc's FY 2025 Numbers and What They Signal
Expect EPAM's fair value to reach 59.38
Popular Narratives
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026
